9.2.6 Laboratory Test Result Abnormalities ..................................................... 9.2.7 Potential Drug-induced Liver Injury ....................................................... 9.2.8 Other Safety Considerations .................................................................... 9.3 Overdose ........................................................................................................... 9.4 Safety ................................................................................................................ 9.4.1 Physical Examinations ............................................................................. 9.4.2 Vital Signs ................................................................................................ 9.4.3 Electrocardiograms ................................................................................. 9.4.4 Clinical Safety Laboratory Assessments .................................................. 9.4.5 Imaging Safety Assessment ...................................................................... 9.5 Pharmacokinetic and Immunogenicity Assessments ........................................ 9.6 Pharmacodynamics ...........................................................................................